Konstantinos Arnaoutakis, MD
Dr. Konstantinos Arnaoutakis is a medical oncologist at the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences, where he specializes in the care of patients diagnosed with lung cancer and malignant pleural mesothelioma.
In treating patients diagnosed with thoracic and other malignancies, Dr. Arnaoutakis relies on traditional treatments including chemotherapy, radiation, and surgery, along with innovative new immunotherapy options. He is keenly aware of how much fear patients feel when they are diagnosed with cancer, and he works collaboratively with a multidisciplinary team to create a treatment plan that meets their condition as well as their emotional and social needs.[2]
Professional Memberships and Activities
Dr. Arnaoutakis is a member of the American Medical Association, the American College of Physicians, the American Society of Clinical Oncology, and the American Society of Hematology.[1]
Research
Dr. Arnaoutakis’ research interests center on lung cancer, head and neck cancers, and genitourinary cancers. He is actively involved in numerous clinical trials, including the following four trials that are currently recruiting patients:[2]
- Pragmatica-Lung: A Prospective Randomized Study of Ramucirumab (LY3009806; NSC 749128) Plus Pembrolizumab (MK-3475; NSC 776864) Versus Standard of Care for Participants Previously Treated With Immunotherapy for Stage IV or Recurrent Non-Small Cell Lung Cancer
- LUNGMAP: A Master Protocol To Evaluate Biomarker-Driven Therapies And Immunotherapies In Previously-Treated Non-Small Cell Lung Cancer (Lung-Map Screening Study)
- Evaluation of Spinal Cord Ischemia and Mortality and Morbidity After Endovascular Repair of Pararenal and Thoracoabdominal Aortic Aneurysm Using Surgeon-Modified Endografts
- A Randomized Phase II Study of Carboplatin and Pemetrexed w/ or w/o Selpercatinib in Participants With Non-Squamous RET Fusion-Positive Stage IV Non-Small Cell Lung Cancer and Progression of Disease on Prior RET Directed Therapy (Lung-MAP Sub-Study)
Dr. Arnaoutakis’ recent publications include:[3]
- Stem Cell Theory of Cancer: Implications for Translational Research from Bedside to Bench. Shi-Ming Tu, Sunny R Singh, Konstantinos Arnaoutakis, Sindhu Malapati, Sajjad A Bhatti, Aron Y Joon, Omar T Atiq, Louis L Pisters>; Cancers. 2022 Jul 9
- Hematology/Oncology Fellowship Programs’ Participation in the Quality Oncology Practice Initiative. Issam Makhoul, Michael Anders, Robert Siegel, Anne Chiang, Merry-Jennifer Markham, Ronald C Chen, Sarah Mougalian, Konstantinos Arnaoutakis, Meredith Giuliani, Annie I…>; JCO Oncology Practice. 2022 Jul 1
- An advanced molecular medicine case report of a rare human tumor using genomics, pathomics, and radiomics. Li Ma, Erich A Peterson, Ik Jae Shin, Jason Muesse, Katy Marino, Mathew A Steliga, Omar Atiq, Konstantinos Arnaoutakis, Christopher Wardell, Jacob Wooldridge, Fred Pri…>; Frontiers in Genetics. 2022 Jan 1
